Rare Stock Picks In March 2026 - From 23 Discerning Analysts [Seeking Alpha]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Seeking Alpha
The following new investment ideas were made by analysts who have NO OTHER Buy/Strong Buy recommendations in the past 3 months, making them rare selections. Following the sell-off over the past month, are there any compelling investment ideas out there that may have flown under your radar? Below is a list of March Buy recommendations made by analysts who had no other bullish recommendations over the past 3 months. For your directory assistance, we've classified the opportunities by sector. Healthcare Ionis Pharmaceuticals IONS ) - Longtime analyst Milkweed says the projected $2B+ peak revenue for Olezarsen is highly conservative given the U.S. addressable market, and the value of the rest of their extensive pipeline is another catalyst. - Ionis Pharmaceuticals' Peak Olezarsen Revenues Are Likely Very Conservative Humana HUM ) - Individual investor Natural Born Value Seeker says despite near-term margin compression and operational risk, a DCF-based valuation of $330 per sh
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) [Yahoo! Finance]Yahoo! Finance
- FDA Priority Review Puts Ionis Zilganersen At Center Of Rare-Disease Story [Yahoo! Finance]Yahoo! Finance
- Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.MarketBeat
- Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.MarketBeat
IONS
Earnings
- 2/25/26 - Miss
IONS
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 3/31/26 - Form 144
- IONS's page on the SEC website